Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.
3 points, 1 comments on Hacker News
3 points, 1 comments on Hacker News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
As humanity gets closer to the possibility of long-term interplanetary travel, psychologists have started raising concerns about astronauts' mental health. Researchers at Texas A&M University conducted research on sailors in an isolated environment to address these concerns using virtual reality...
An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the companies announced Wednesday. The positive results mean a potentially life-extending treatment is on...